期刊文献+

羊布鲁氏菌病活疫苗(S2株)灌服免疫绵羊试验 被引量:3

Immunity Test of Live Brucellosis Vaccine(S2 strain)in Sheep
下载PDF
导出
摘要 为了解羊布鲁氏菌病活疫苗(S2株)免疫效果和免疫副反应情况,为羊布病免疫和检疫提供参考依据,以科学开展布病防控工作。对本地布病抗体检测为阴性的绵羊灌服含100亿活菌的S2弱毒活疫苗,在免疫后第38、77天,用虎红平板凝集试验进行血清抗体检测,比对我市已完成的羊布鲁氏菌病活疫苗(M5株)免疫试验和甘肃省河西地区其他市州布病S2疫苗免疫结果,得出羊布病疫苗S2株免疫效果差于羊布病疫苗M5株,免疫副反应也较轻,但应注意免疫方式方法,开展S2苗灌服免疫,建议实施选择性免疫,不免老、弱、病、残、幼羊。目前来看,布病S2苗仍是国内羊免疫的首选疫苗。 To investigate the immune effects and side effects in sheep immunized with live Brucellosis vaccine(S2 strain),provide reference for immunization and quarantine of sheep Brucellosis,scientifically carry out prevention and control of brucellosis.Selecting native sheep negative for Brucellosis antibodies test,oral immunization of 10 billion CFU live Brucellosis vaccine(S2 strain),at the 38th and 77th day after immunization,the antibodies were detected by Rose Bengal plate agglutination test,compare the immunity test of live Brucellosis vaccine(M5 strain)in sheep that Jinchang city completed and the immune results of Brucellosis vaccine(S2 strain)in other cities in the west of Yellow River in Gansu Province.It is concluded that the immune effect of the sheep Brucellosis vaccine(S2 strain)is worse than the sheep Brucellosis vaccine(M5 strain),at the same time,the immune side effects are lighter,however,when carrying out live Brucellosis vaccine(S2 strain)immunization,attention should be paid to immunization methods,recommended for selective immunization,don't immune old,weak,sick,disabled,young sheep.For now,Brucellosis vaccine(S2 strain)remains the first choice for sheep immunization in China.
作者 余银隆 程文杰 王世雷 祁世栋 赵燕荣 YU Yin-long;CHENG Wen-jie;WANG Shi-lei;QI Shi-dong;ZHAO Yan-rong(Jinchang Animal Disease Prevention and Control Center,Jinchang Gansu 737100,China)
出处 《畜牧兽医杂志》 2020年第6期82-83,86,共3页 Journal of Animal Science and Veterinary Medicine
关键词 羊布病S2疫苗 绵羊 灌服免疫 Brucellosis vaccine(S2 strain) sheep oral immunization
  • 相关文献

参考文献3

二级参考文献120

  • 1高淑芬,冯静兰.中国布鲁氏菌病及其防治(1982-1991)[M].北京:中国科技出版社,1991.
  • 2孙承恩.布鲁氏菌104M活菌苗不同免疫途径的探讨[J].宁夏医学杂志,1985,(1):20-21.
  • 3Moreno E. Retrospective and prospective perspectives on zoonot- ic brucellosis[J]. Front Microbiol, 2014, 5(213): 1-18. DOI: 10. 3389/fmicb. 2014. 00213.
  • 4Galinska EM, Zagorski J. Brucellosis in humans-etiology, diag- nostics, clinical forms[J]. Ann Agric Environ Med, 2013, 20 (2) : 233-238.
  • 5Perkins SD, Smither SJ, Atkins HS. Towards a Brucella vac- cine for humans[J]. FEMS Microbiol Rev, 2010, 34(3): 379-394.
  • 6Vershilova P. The use of live vaccine for vaccination of human beings against brucellosis in the USSR[J]. Bull WHO, 1961, 24 (1): 85-89.
  • 7Deqiu S, Donglou X, Jiming Y. Epidemiology and control of bru- cellosis in China[J]. Vet Microbiol, 2002, 90 (1): 165-182. DO1: 10. 1016/S0378-1135(02)00252-3.
  • 8Spink WW, Hall JW, Finstad J, et al. Immunization with viable Brucella organisms. Results of a safety test in humans[J]. Bull World Health Organ, 1962, 26(1) : 409-419.
  • 9Elberg SS, Faunce W Jr. Immunization against Brucella infec tion: 10. The relative immunogenicity of Brucella abortus strain 19 BA and Brucella melitensis strain Rev I in Cynomolgus philip- pinensis[J]. Bull WHO, 1964, 30(5): 693.
  • 10Hadjichristodoulou C, Voulgaris P, Toulieres L, et al. Toler ance of the human brucellosis vaccine and the intradermal reac- tion test for brucellosis[J]. Eur J Clin Microbiol Infect Dis, 1994, 13(2): 129 134. DOI: 10,1007/BF01982185.

共引文献38

同被引文献44

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部